← Leaderboards
Bo Liang
Iview Therapeutics, Inc.
$903,094
Attributed
$903,094
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2016–19$500K$375K$250K$125K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$903,094 · 2
By mechanism
R43$903,094 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsOryctolagus CuniculusIonsIn VivoLocal Anti-Infective AgentsOphthalmologyDrug Delivery SystemsFungusInfectionIn VitroLicensingAnti-Bacterial AgentsNew ZealandOperative Surgical ProceduresCharacteristicsCommercializationFormulationEquilibriumHourAreaBacteriaIn SituIrritationPharmacologic Substance
Grant awards (4)
In-situ gel of Povidone Iodine/Budesonide as Sustained Nasal Drug Delivery for the Treatment of Chronic Rhinosinusitis$300,000
R43 · FY2019 · AI · contact PI
In-situ gel of Povidone Iodine/Budesonide as Sustained Nasal Drug Delivery for the Treatment of Chronic Rhinosinusitis$279,745
R43 · FY2018 · AI · contact PI
Novel Extended Release Povidone Iodine Ophthalmic Drop for Viral Conjunctivitis$25,000
R43 · FY2017 · EY · contact PI
Novel Extended Release Povidone Iodine Ophthalmic Drop for Viral Conjunctivitis$298,349
R43 · FY2016 · EY · contact PI